The Booster™ balloon catheter is designed to increase pressure in the heart venules and capillaries, improving oxygen delivery to the ischemic myocardium and ultimately improving patient outcomes. Unlike other technologies, it is intuitive and simple to use with no need for dedicated personnel or expensive consoles. Intratech has secured a major investment from a key strategic corporation in the interventional cardiology field and has a comprehensive patent family with patents granted globally. The company has launched its First-In-Human clinical trial in 2021 and has promising pre-clinical results.